Skip to content

Observational study for endoscopic treatment of esophageal early cancer

Observational study for endoscopic treatment of esophageal early cancer

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900027326
Enrollment
Unknown
Registered
2019-11-09
Start date
2019-11-01
Completion date
Unknown
Last updated
2019-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early esophageal cancer

Interventions

Case series:Nil

Sponsors

Nanfang Hospital, Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 40-69 years old; 2. ESCC was diagnosed as ESCC according to the above diagnostic criteria. Due to the needs of the disease, endoscopic therapy was proposed according to the clinical diagnosis and treatment specifications; 3. Agree to participate in the study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Those who have serious mental retardation or language communication obstacle; 2. Refuse to accept this study.

Design outcomes

Primary

MeasureTime frame
Complete resection rate;Block removal rate;Recurrence rate;3 years and 5 years recurrence rate and survival rate;

Countries

China

Contacts

Public ContactLiu Side

Nanfang Hospital, Southern Medical University

liuside2011@163.com+86 13902212459

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026